Delivering Multiple siRNAs for the Treatment of Oncology & Fibrosis

Time: 1:50 pm


  • Our proprietary polypeptide nanoparticle (PNP) platform can carry multiple siRNA sequences to viable targets
  • Silencing more than one target using PNP can have profound improvements on the efficacy of RNAi therapeutics
  • Sirnaomics is currently driving multiple therapeutic programs through pre-clinical and clinical development